The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

January 18, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Rheumatic Diseases
Interventions
OTHER

pharmacists involved OPCSP

This was an open labelled randomised study. Rheumatic diseases patients were recruited and arbitrarily divided into the intervention group (usual care plus OPCSP) and the non-intervention group (usual care only). Those enrolled in the research were scheduled for follow-up for eight consecutive visits. Improvements in lab results and direct costs were compared longitudinally (pre and post analysis) between the groups.

Trial Locations (1)

201112

South Campus, Ren Ji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT03024307 - The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases | Biotech Hunter | Biotech Hunter